Menopausal hormone therapy and the risk of systemic lupus erythematosus and systemic sclerosis: a population-based nested case-control study

Systemic Lupus Erythematosus

Incidence and risk of arterial and venous thrombotic events in Systemic Lupus Erythematosus patients: a population-based study

Rheumatology (Oxford)

Ojeda-Fernandez L, Calvisi S, Torrigiani G, Tettamanti M, Fortino I, Roncaglioni C, Baviera M

doi: 10.1093/rheumatology/keae496

Systemic Lupus Erythematosus

Efficacy and safety of sequential therapy with subcutaneous belimumab and one cycle of rituximab in patients with systemic lupus erythematosus: the phase 3, randomised, placebo-controlled BLISS-BELIEVE study

Ann Rheum Dis

Aranow C, Allaart CF, Amoura Z, Bruce IN, Cagnoli PC, Chatham WW, Clark KL, Furie R, Groark J, Urowitz MB, van Vollenhoven R, Daniels M, Fox NL, Gregan YI, Henderson RB, van Maurik A, Ocran-Appiah JC, Oldham M, Roth DA, Shanahan D, Tak PP, Teng YO

doi: 10.1136/ard-2024-225686

Rheumatoid Arthritis

Impact of systemic inflammation and disease activity on the incidence of interstitial lung disease in patients with rheumatoid arthritis - a nested case-control study within the German biologics register RABBIT

Arthritis Res Ther

Ramien R, Rudi T, Alten R, Krause A, Schneider M, Schaefer M, Strangfeld A, Meissner Y

doi: 10.1186/s13075-024-03449-9

Systemic Sclerosis

Immunosuppressive therapy to treat newly diagnosed primary heart involvement in patients with systemic sclerosis: An Italian cardiac magnetic resonance based study

Semin Arthritis Rheum

De Luca G, De Santis M, Batani V, Tonutti A, Campochiaro C, Palmisano A, Vignale D, Motta F, Monti L, Francone M, Selmi C, Matucci-Cerinic M, Esposito A, Dagna L

doi: 10.1016/j.semarthrit.2024.152622

Systemic Lupus Erythematosus

Efficacy and Safety of Sodium-Glucose Co-Transporter 2 Inhibitors for the Primary Prevention of Cardiovascular, Renal Events and Safety Outcomes in Patients with Systemic Lupus Erythematosus and Comorbid Type 2 Diabetes: A Population-based Target Trial Emulation

Arthritis Rheumatol

Ma KS, Lo JE, Kyttaris VC, Tsokos GC, Costenbader KH

doi: 10.1002/art.43037

Systemic Lupus Erythematosus

Clinical Presentation, Care Pathways, and Delays in Access to Specialized Care in Patients With Systemic Lupus Erythematosus: A Study From Lupus Midwest Network (LUMEN 💡)

Arthritis Care Res (Hoboken)

Sanchez-Rodriguez A, Meade-Aguilar JA, Yang JX, Figueroa-Parra G, Hanson AC, Langenfeld HE, Thanarajasingam U, Chamberlain AM, Greenlund KJ, Barbour KE, Crowson CS, Duarte-García A

doi: 10.1002/acr.25445

Melanoma and Skin Cancer

Impact of particulate matter exposure on melanoma risk: A multicentre case-control study

J Eur Acad Dermatol Venereol

Bellinato F, Adami G, Reatini MA, Cattani G, Cannizzaro MV, Del Regno L, Peris K, Gisondi P, Girolomoni G

doi: 10.1111/jdv.20539

Further Publications Immunology

Risk of Heart Failure in Patients With Immune-Mediated Inflammatory Diseases: A Population-Based Study

J Rheumatol

Koppikar S, Kuriya B, Udell JA, Yu B, Chu A, Lee DS, Widdifield J, Eder L

doi: 10.3899/jrheum.2024-0866

Autoimmune Disease

Primary Cesarean delivery and future risk of maternal autoimmune disease: A population-based cohort study

J Autoimmun

Scime NV, Grandi SM, De Vera MA, Dennis CL, Boblitz A, Brown HK

doi: 10.1016/j.jaut.2025.103370

Related content

Incidence and risk of arterial and venous thrombotic events in Systemic Lupus Erythematosus patients: a population-based study

Efficacy and safety of sequential therapy with subcutaneous belimumab and one cycle of rituximab in patients with systemic lupus erythematosus: the phase 3, randomised, placebo-controlled BLISS-BELIEVE study

Impact of systemic inflammation and disease activity on the incidence of interstitial lung disease in patients with rheumatoid arthritis - a nested case-control study within the German biologics register RABBIT

Immunosuppressive therapy to treat newly diagnosed primary heart involvement in patients with systemic sclerosis: An Italian cardiac magnetic resonance based study

Efficacy and Safety of Sodium-Glucose Co-Transporter 2 Inhibitors for the Primary Prevention of Cardiovascular, Renal Events and Safety Outcomes in Patients with Systemic Lupus Erythematosus and Comorbid Type 2 Diabetes: A Population-based Target Trial Emulation

Clinical Presentation, Care Pathways, and Delays in Access to Specialized Care in Patients With Systemic Lupus Erythematosus: A Study From Lupus Midwest Network (LUMEN 💡)

Impact of particulate matter exposure on melanoma risk: A multicentre case-control study

Risk of Heart Failure in Patients With Immune-Mediated Inflammatory Diseases: A Population-Based Study

Primary Cesarean delivery and future risk of maternal autoimmune disease: A population-based cohort study